Research - When investing in development-stage biotech companies, evidence of success is everything. Therefore, investors should always start with the question: Is the company’s product candidate a … Continue Reading
Read nowInterviews - The CPAP (Continuous Positive Airway Pressure) equipment market is about to enter a pivotal time. The Centers for Medicare and Medicaid (CMS) instituted a round … Continue Reading
Read nowLong Ideas - It’s not easy to do, but buying when there’s blood in the streets is a way many have scored big on Wall Street. Take our … Continue Reading
Read nowLong Ideas - Anthera Pharmaceuticals (NASDAQ:ANTH) is getting another lift Wednesday, as the company announced additional data from the Phase IIb PEARL-SC study for its primary value driver, … Continue Reading
Read nowLong Ideas - Transcept Pharmaceuticals (NASDAQ:TSPT) has struggled to show compelling demand for its primary value driver, Intermezzo, which is marketed by partner, Purdue Pharmaceuticals in the U.S. … Continue Reading
Read nowLong Ideas - With the latest developments on the proposals to acquire Complete Genomics (NASDAQ:GNOM), investors have the chance to own shares of the life sciences company with … Continue Reading
Read nowLong Ideas - In the next several weeks, Keryx Biopharmaceuticals (KERX) will release results from 4 key Phase III trials for its primary drug candidate, Zerenex. The drug … Continue Reading
Read now
